After the news that Novartis failed to secure an Indian patent for Glivec, the patenting woes of Western pharma in India seem to continue as Merck are denied interim relief in a patent case against Glenmark. The decision came within days of Merck’s subsidiary, MSD India, dragging the domestic company to court over the [...]
Post Novartis Glivec case ruling competition between MNC pharmaceuticals & Indian generic companies gets fierce as US based Merck Sharp & Dohme (MSD), the third largest pharma company by revenues , has filed a patent infringement suit with Delhi High court against domestic generic company Glenmark Pharmaceuticals. MSD move comes a week after Glenmark [...]
India’s Supreme Court has set an important precedent in refusing to grant a patent to Novartis for an updated version of its cancer drug Glivec. The verdict will allow generic drug makers within the country to continue selling cheap versions of the drug, which is used to treat chronic myeloid leukemia and other cancers. [...]
Every Morning in a Indian House starts with a cup of tea & a news on smartphone companies like HTC, Motorola, Apple fighting the patent wars, but it seems that the Smartphone patent war has been finally arrived in India too. Ericsson, world’s biggest telecom network equipment maker has recently filed a patent infringement [...]
MNCs might have been waiting for this. After issuance of first compulsory license by Indian Patent Office to Natco from Bayer's for their drug Gleevac which is an anticancer drug, these MNC companies were already tensed that when some new generic company will rise up to the situation and file for compulsory license to [...]
Most of us have grown up in India hearing facts about how Indian minds are the sharpest in the world and how most NASA scientists and Intel engineers are Indians. Does it really make us proud boasting about how an Indian has discovered something new in a foreign laboratory and commercialized it to success [...]
